Supplemental New Drug Application

From HL7Wiki
Revision as of 19:03, 26 September 2008 by Donohd00 (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

A Supplemental New Drug Application is an application that when approved will allow a company to make changes in a product that already has an approved new drug application (NDA).

Additional Regional Definitions and Synonyms

None